Anatomy, Thorax, Thoracic Duct

Structure and Function

The function of the thoracic duct is to transport lymph back into the circulatory system. Interstitial fluid is collected by lymph capillaries from the interstitial space. Lymph then moves through lymphatic vessels to lymph nodes. Lymphatic vessels merge to create the lymphatic ducts which drain into the venous system. The thoracic duct delivers an estimated 1.38 mL/kg/hour of lymph to the venous system.

Embryology

During the sixth week of development of the human embryo, the early lymphatic system is composed of blunt buds near the base of the neck. Six lymph sacs form by the end of the embryonic period. These lymph sacs are the cisterna chyli, two jugular lymph sacs, two iliac lymph sacs, and a retroperitoneal lymph sac. Lymphatic vessels develop to connect these sacs and form the early lymphatic system. The thoracic duct develops from lymphatic trunks on either side of the aorta that anastomoses to form a channel from the jugular lymph sacs to the cisterna chyli. Trunks continue to anastomose and enlarge, forming embryonic right and left thoracic ducts. The adult thoracic duct is derived from both of these embryonic thoracic ducts. The right primitive thoracic duct eventually develops into the lower adult thoracic duct whereas the left primitive thoracic duct develops into the upper portion of the adult thoracic duct.

Physiologic Variants

The typical anatomy described above is present in only about 50% of individuals. There are many anatomic variations of the thoracic duct. A cisterna chyli is present in about half of individuals. When embryologic lymphatic trunks converge above the T12 vertebral level, the cisterna chyli is generally absent, but there may be dilation of lower lumbar trunks.

In the embryo, portions of a bilateral system of lymphatic trunks anastomose and develop while portions atrophy. Failure of the typical pattern leads to anatomic variations of the thoracic duct. A common variation is a bifid lower aspect of the trunk caused by embryonic right and left lymphatic trunks failing to fuse. Another variation is the lower thoracic duct being replaced by a plexus of lymphatic vessels and forming a single duct higher in the mediastinum. Two rare variations include complete bilateral thoracic ducts and termination of the duct into the azygos system.

Variations in termination also exist. In the majority of cases, the duct terminates on the left side. In 2% to 3% of cases, the duct empties on the right, and bilaterally in up to 1.5% of cases. In over 95% of cases, the thoracic duct terminates in the internal jugular vein, the subclavian vein, or the angle between the two. The remaining 5% include termination in the external jugular vein, vertebral vein, brachiocephalic vein, suprascapular vein, and transverse cervical vein. The thoracic duct can also terminate as a single vessel (up to 87.5%), bilateral ducts (up to 25%), or several terminal branches (up to 7%).

The thoracic duct displays physiologic adaptation to certain disease processes by increasing in diameter. These disease states include congestive heart failure, cirrhosis or the liver, portal hypertension, and malignancy.[4][5]

Surgical Considerations

Procedures within the thoracic cavity risk injuring or obstructing the duct which could result in chylothorax. The long course of the thoracic duct predisposes it to traumatic injury during thoracic, cardiac, or head and neck surgeries. Frequent physiologic variants also make avoiding the duct during surgery somewhat difficult. The thoracic duct is particularly vulnerable to trauma during esophageal surgery. Certain noninvasive procedures also risk iatrogenic duct injury such as a central line placement. Occlusion of the thoracic duct also results in chylous extravasation although this is much less common compared to injury.

Dietary changes, including decreasing intake of fat and increasing intake of medium chain triglycerides, can be used as an initial conservative approach to treating low chyle output of less than 1 L/day. Bowel rest and lipid-free total parenteral nutrition is another option. If chyle output is over 1 L/day, thoracic duct ligation or percutaneous embolization must be considered.

Clinical Significance

As a central structure to lymphatic flow and movement, thoracic duct dysfunction and resulting chyle accumulation is concerning for malignancy. Lymph from organs can drain directly into the thoracic duct without passing a lymph node. This anodal route has been observed for the diaphragm, esophagus, and parts of the lungs. The drainage pattern may play a role in the prognosis of cancers of these organs. This pattern may also explain the presence of distant metastases without lymph node involvement. 

The Virchow node, a lymph node located at the base of the neck where the duct generally terminates, can be enlarged in cases of malignancy and may obstruct drainage of the thoracic duct. When there is an obstruction of the thoracic duct, lymph collects in the pleural cavity. This formation of chylothorax can be the first sign of malignancy.